Controlled Drug Delivery Systems: Current Status and Future Directions

The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to ach...

Full description

Saved in:

Bibliographic Details
Published in	Molecules (Basel, Switzerland) Vol. 26; no. 19; p. 5905
Main Authors	Adepu, Shivakalyani, Ramakrishna, Seeram
Format	Journal Article
Language	English
Published	Basel MDPI AG 29.09.2021 MDPI
Subjects	Bioavailability Carbon dioxide Classification controlled release dosage forms Drug delivery systems Drug dosages Ingredients intelligent biomaterials nano-drug delivery Oral administration Permeability pharmacokinetics Review smart and stimuli-responsive delivery Taste
Online Access	Get full text

Cover

Loading…

Abstract	The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery.
AbstractList	The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery.The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery. The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery.
Author	Adepu, Shivakalyani Ramakrishna, Seeram
AuthorAffiliation	Center for Nanofibers and Nanotechnology, National University of Singapore (NUS), 21 Lower Kent Ridge Rd, Singapore 119077, Singapore
AuthorAffiliation_xml	– name: Center for Nanofibers and Nanotechnology, National University of Singapore (NUS), 21 Lower Kent Ridge Rd, Singapore 119077, Singapore
Author_xml	– sequence: 1 givenname: Shivakalyani orcidid: 0000-0003-0784-1120 surname: Adepu fullname: Adepu, Shivakalyani – sequence: 2 givenname: Seeram orcidid: 0000-0001-8479-8686 surname: Ramakrishna fullname: Ramakrishna, Seeram
BookMark	eNp9kU9vFCEYh4mpsX_0A3ibxIuXtbzALIwHE7Pr2iZNPFTPhIF3VjbMUGFost--rNsYWxNPEHh-T174nZOTKU5IyFugHzjv6OUYA9oSMLMldG1H2xfkDASjC05Fd_LX_pSc57yjlIGA9hU55WIpQAh5RjarOM0phoCuWaeybdYY_D2mfXO7zzOO-WOzKinhNDe3s5lLbszkmk2ZS8Jm7RPa2ccpvyYvBxMyvnlcL8iPzZfvq6vFzbev16vPNwsrJJ0XAM4NQgJzCB1ljgrlrGO25_1SDXxgyra9tayXwtVhlWA9H0ACcKNQgOUX5ProddHs9F3yo0l7HY3Xvw9i2mqTZm8D6iq1nQUnnVKC9swgY3QphWTcDapT1fXp6Lor_YjO1jcmE55In95M_qfexnutWmCcsip4_yhI8VfBPOvRZ4shmAljyZq1ChSrHUBF3z1Dd7GkqX7VgaJdxyVvKwVHyqaYc8LhzzBA9aFx_U_jNSOfZayvRflDrcaH_yQfALdrtA0
CitedBy_id	crossref_primary_10_1016_j_nxnano_2023_100027 crossref_primary_10_3390_ijms252111799 crossref_primary_10_1080_09205063_2024_2396221 crossref_primary_10_3390_polym15081810 crossref_primary_10_1021_acsmaterialslett_2c00610 crossref_primary_10_1002_app_56630 crossref_primary_10_1016_j_eurpolymj_2025_113795 crossref_primary_10_1039_D4NR00554F crossref_primary_10_3390_biomimetics9050295 crossref_primary_10_1021_acsabm_3c00224 crossref_primary_10_1039_D3NR00807J crossref_primary_10_3390_ma16247550 crossref_primary_10_1016_j_procbio_2023_12_016 crossref_primary_10_1080_10717544_2022_2121450 crossref_primary_10_1016_j_jsps_2024_102064 crossref_primary_10_1016_j_ijbiomac_2024_135085 crossref_primary_10_3390_pharmaceutics15122675 crossref_primary_10_1039_D3TB00057E crossref_primary_10_33380_2305_2066_2024_13_3_1793 crossref_primary_10_1080_08982104_2024_2410748 crossref_primary_10_1007_s44174_024_00218_9 crossref_primary_10_1039_D4TB00599F crossref_primary_10_32352_0367_3057_5_24_04 crossref_primary_10_1155_2022_1231446 crossref_primary_10_3390_pharmaceutics16020186 crossref_primary_10_3390_ph17030315 crossref_primary_10_1007_s11051_024_06165_2 crossref_primary_10_1007_s42247_023_00584_y crossref_primary_10_1177_20503121231225319 crossref_primary_10_1002_admi_202202286 crossref_primary_10_15406_ppij_2024_12_00452 crossref_primary_10_31436_jop_v3i1_190 crossref_primary_10_1080_21655979_2024_2401269 crossref_primary_10_3390_app14072926 crossref_primary_10_3389_fbioe_2024_1509397 crossref_primary_10_3390_nano13111782 crossref_primary_10_1016_j_apmt_2024_102138 crossref_primary_10_1016_j_ijbiomac_2023_129136 crossref_primary_10_1186_s12951_024_02352_4 crossref_primary_10_1016_j_jddst_2024_105656 crossref_primary_10_1016_j_matdes_2022_111287 crossref_primary_10_1021_acsomega_3c03619 crossref_primary_10_3390_pharmaceutics15041234 crossref_primary_10_1021_acsbiomaterials_4c00218 crossref_primary_10_1016_j_jddst_2023_104254 crossref_primary_10_2174_0115672018279628231221105210 crossref_primary_10_1016_j_ntm_2024_100042 crossref_primary_10_1016_j_cartre_2024_100407 crossref_primary_10_3390_cancers16112030 crossref_primary_10_1016_j_molliq_2024_126767 crossref_primary_10_1016_j_colsurfa_2023_131450 crossref_primary_10_1016_j_carbpol_2023_121177 crossref_primary_10_1016_j_molliq_2024_125793 crossref_primary_10_3390_app14031132 crossref_primary_10_1039_D4PM00186A crossref_primary_10_1002_jemt_24667 crossref_primary_10_3390_pharmaceutics16091153 crossref_primary_10_1039_D2SM01624A crossref_primary_10_1016_j_ijbiomac_2024_136149 crossref_primary_10_1016_j_ijbiomac_2024_137238 crossref_primary_10_1080_87559129_2024_2347478 crossref_primary_10_1007_s10971_025_06729_1 crossref_primary_10_2174_0122106812264809231023072013 crossref_primary_10_1016_j_eurpolymj_2024_113250 crossref_primary_10_1039_D2TB00942K crossref_primary_10_3390_polym15153173 crossref_primary_10_1016_j_jddst_2023_105224 crossref_primary_10_3390_molecules28155694 crossref_primary_10_1021_acs_jchemed_2c00422 crossref_primary_10_1007_s10853_024_10490_1 crossref_primary_10_1097_CAD_0000000000001612 crossref_primary_10_3390_antibiotics13111055 crossref_primary_10_1016_j_apsadv_2023_100550 crossref_primary_10_54097_hset_v58i_10122 crossref_primary_10_2174_0113816128299356240626114734 crossref_primary_10_1016_j_cej_2023_142522 crossref_primary_10_1109_TMBMC_2024_3521984 crossref_primary_10_1134_S0965545X2460011X crossref_primary_10_1021_acsaom_3c00282 crossref_primary_10_4155_tde_2022_0070 crossref_primary_10_1016_j_mtcomm_2023_107938 crossref_primary_10_1007_s12032_025_02649_w crossref_primary_10_2174_2667387817666230907093403 crossref_primary_10_1039_D4PM00296B crossref_primary_10_1021_acssynbio_2c00655 crossref_primary_10_1021_acs_molpharmaceut_4c00269 crossref_primary_10_3390_gels8110738 crossref_primary_10_1016_j_matchemphys_2025_130477 crossref_primary_10_1007_s12668_024_01779_1 crossref_primary_10_1016_j_reactfunctpolym_2024_105867 crossref_primary_10_34172_jhp_2024_48111 crossref_primary_10_3390_jfb15020026 crossref_primary_10_3390_pharmaceutics15112549 crossref_primary_10_1016_j_jddst_2023_105281 crossref_primary_10_3390_polym16050643 crossref_primary_10_1002_admt_202300810 crossref_primary_10_1051_matecconf_202440403003 crossref_primary_10_2174_0113816128309675240530060752 crossref_primary_10_1080_17435889_2024_2421157 crossref_primary_10_3390_ijms241914983 crossref_primary_10_7759_cureus_19674 crossref_primary_10_22159_ijap_2025v17i2_52161 crossref_primary_10_2147_IJN_S432970 crossref_primary_10_1007_s42247_023_00551_7 crossref_primary_10_1016_j_ejmech_2023_115780 crossref_primary_10_1021_acsanm_3c04219 crossref_primary_10_1016_j_cossms_2024_101213 crossref_primary_10_1016_j_ijpharm_2023_123174 crossref_primary_10_5802_crchim_222 crossref_primary_10_1007_s12668_024_01743_z crossref_primary_10_1016_j_matchemphys_2025_130646 crossref_primary_10_1016_j_matpr_2023_04_481 crossref_primary_10_1038_s41467_024_46732_8 crossref_primary_10_3390_pharmaceutics16101344 crossref_primary_10_2147_IJN_S442520 crossref_primary_10_3390_ijms24054801 crossref_primary_10_3390_pharmaceutics16091200 crossref_primary_10_1016_j_jddst_2024_106543 crossref_primary_10_1186_s12906_023_04212_4 crossref_primary_10_1039_D4TB01563K crossref_primary_10_1208_s12249_024_02867_x crossref_primary_10_3390_pharmaceutics15112556 crossref_primary_10_1007_s11696_024_03463_w crossref_primary_10_1016_j_ijbiomac_2023_125800 crossref_primary_10_7759_cureus_71040 crossref_primary_10_1002_slct_202403846 crossref_primary_10_1016_j_molstruc_2023_135959 crossref_primary_10_1186_s12906_022_03741_8 crossref_primary_10_3390_biomedicines12061168 crossref_primary_10_3390_cancers16020461 crossref_primary_10_1002_nano_202300099 crossref_primary_10_1109_TBME_2024_3354856 crossref_primary_10_1080_17425247_2023_2263360 crossref_primary_10_1080_02652048_2024_2423631 crossref_primary_10_1590_0104_1428_20230079 crossref_primary_10_34133_bmr_0147 crossref_primary_10_22159_ijap_2023v15i5_48453 crossref_primary_10_3390_gels10110731 crossref_primary_10_1016_j_jddst_2024_106548 crossref_primary_10_3390_app14051809 crossref_primary_10_3390_pharmaceutics15041312 crossref_primary_10_22159_ajpcr_2023_v16i4_46456 crossref_primary_10_1021_acsomega_2c06034 crossref_primary_10_3390_pharmaceutics14081567 crossref_primary_10_3390_pharmaceutics16020198 crossref_primary_10_1080_00222348_2024_2372523 crossref_primary_10_1016_j_actbio_2024_03_019 crossref_primary_10_2174_0113816128304924240527113111 crossref_primary_10_3390_pharmaceutics15051364 crossref_primary_10_1186_s42269_024_01163_9 crossref_primary_10_3389_fbioe_2024_1511149 crossref_primary_10_3390_antiox12030633 crossref_primary_10_1016_j_cej_2024_157037 crossref_primary_10_1016_j_molstruc_2024_139149 crossref_primary_10_1080_15476286_2024_2328440 crossref_primary_10_1515_ntrev_2022_0525 crossref_primary_10_1002_adhm_202301759 crossref_primary_10_1002_adhm_202302969 crossref_primary_10_22270_jddt_v14i6_6619 crossref_primary_10_1007_s10853_024_09774_3 crossref_primary_10_1021_jacs_3c05941 crossref_primary_10_1016_j_colsurfa_2023_131763 crossref_primary_10_1088_1748_605X_acfd78 crossref_primary_10_3390_molecules28124705 crossref_primary_10_1111_jgh_16490 crossref_primary_10_1007_s10924_024_03391_6 crossref_primary_10_1021_acs_biomac_3c00179 crossref_primary_10_18311_ti_2023_v30i4_33447 crossref_primary_10_3390_pharmaceutics15051499 crossref_primary_10_1515_znc_2024_0208 crossref_primary_10_38124_ijisrt_IJISRT24SEP1199 crossref_primary_10_1016_j_jddst_2024_106406 crossref_primary_10_3390_pharmaceutics16091218 crossref_primary_10_1016_j_jconrel_2025_113619 crossref_primary_10_3390_pharmaceutics15020413 crossref_primary_10_7759_cureus_49399 crossref_primary_10_1016_j_jddst_2024_105797 crossref_primary_10_1016_j_jddst_2024_105436 crossref_primary_10_1016_j_aiepr_2023_04_002 crossref_primary_10_1016_j_jcou_2023_102518 crossref_primary_10_3390_ph16060821 crossref_primary_10_3390_ijms242115599 crossref_primary_10_1021_acsomega_3c08009 crossref_primary_10_3390_biom14050560 crossref_primary_10_3390_gels10070419 crossref_primary_10_1186_s12896_024_00856_3 crossref_primary_10_1016_j_addr_2023_114824 crossref_primary_10_1039_D2TB02505A crossref_primary_10_1021_acs_biomac_4c00872 crossref_primary_10_1515_polyeng_2023_0191 crossref_primary_10_3390_polym15234563 crossref_primary_10_1002_adma_202307675 crossref_primary_10_1016_j_sajce_2024_08_013 crossref_primary_10_3390_su152316305 crossref_primary_10_3390_polym15173644 crossref_primary_10_1038_s41598_024_55953_2 crossref_primary_10_1016_j_drudis_2024_103936 crossref_primary_10_1007_s11696_022_02185_1 crossref_primary_10_3390_pharmaceutics15051559 crossref_primary_10_1167_tvst_13_6_12 crossref_primary_10_3390_mi15040533 crossref_primary_10_1016_j_molliq_2024_124738 crossref_primary_10_3390_pharmaceutics15030955 crossref_primary_10_30970_sbi_1802_764 crossref_primary_10_1186_s12645_024_00289_9 crossref_primary_10_3389_fonc_2024_1487376 crossref_primary_10_1002_marc_202400903 crossref_primary_10_1016_j_jconrel_2023_08_036 crossref_primary_10_1016_j_phymed_2024_156176 crossref_primary_10_1557_s43578_023_01157_9 crossref_primary_10_1016_j_cej_2024_154772 crossref_primary_10_3390_pharmaceutics15082066 crossref_primary_10_4103_JAPTR_JAPTR_34_24 crossref_primary_10_1007_s40506_023_00269_4 crossref_primary_10_1039_D4RA02337D crossref_primary_10_1039_D4NJ03019B crossref_primary_10_1016_j_ijpharm_2024_124077 crossref_primary_10_1021_acsomega_3c10102 crossref_primary_10_1016_j_ijpharm_2024_125162 crossref_primary_10_1039_D3TB02362A crossref_primary_10_1177_22808000241266487 crossref_primary_10_3390_polym15173631 crossref_primary_10_1007_s11051_024_06074_4 crossref_primary_10_3390_ijms231810755 crossref_primary_10_1002_adem_202400917 crossref_primary_10_1007_s11010_024_05145_3 crossref_primary_10_1016_j_jddst_2025_106631 crossref_primary_10_1016_j_jddst_2024_106432 crossref_primary_10_1016_j_jenvman_2023_119872 crossref_primary_10_1016_j_diamond_2023_109893 crossref_primary_10_1002_adtp_202200320 crossref_primary_10_1016_j_jddst_2024_105582 crossref_primary_10_1038_s41598_023_43689_4 crossref_primary_10_1080_00914037_2022_2058946 crossref_primary_10_1002_smsc_202400201 crossref_primary_10_1016_j_jmbbm_2024_106783 crossref_primary_10_22159_ijpps_2024v16i2_49960 crossref_primary_10_3390_ijms24043188 crossref_primary_10_1016_j_molliq_2025_127139 crossref_primary_10_1002_admt_202301044 crossref_primary_10_3390_biomedicines11020453 crossref_primary_10_1002_cbdv_202400116 crossref_primary_10_1016_j_jddst_2022_103767 crossref_primary_10_3390_synbio2040024 crossref_primary_10_1080_09205063_2024_2438493 crossref_primary_10_1007_s00775_024_02054_0 crossref_primary_10_1039_D4LF00101J crossref_primary_10_1186_s12985_025_02645_6 crossref_primary_10_3390_ma17020456 crossref_primary_10_1002_adma_202312939 crossref_primary_10_1016_j_indcrop_2024_118764 crossref_primary_10_1134_S106377882311008X crossref_primary_10_1088_1361_6528_adad7a crossref_primary_10_1016_j_jddst_2024_105355 crossref_primary_10_1016_j_jddst_2025_106740 crossref_primary_10_54133_ajms_v6i2_786 crossref_primary_10_32604_or_2024_056955 crossref_primary_10_1016_j_biopha_2023_115049 crossref_primary_10_3390_gels10020143 crossref_primary_10_1007_s40005_025_00732_y crossref_primary_10_1039_D3MA00817G crossref_primary_10_3390_toxics11120974 crossref_primary_10_1016_j_ijbiomac_2024_133274 crossref_primary_10_1021_acsmaterialslett_3c00581 crossref_primary_10_3390_medicina60091384 crossref_primary_10_1039_D3RA06857A crossref_primary_10_1016_j_smaim_2023_03_002 crossref_primary_10_1016_j_cej_2025_160379 crossref_primary_10_1016_j_mtcomm_2024_108248 crossref_primary_10_3390_gels11030165 crossref_primary_10_1208_s12249_025_03063_1 crossref_primary_10_1002_app_55610 crossref_primary_10_18231_j_ijpca_2024_003 crossref_primary_10_1021_acsabm_2c00870 crossref_primary_10_1016_j_molstruc_2024_138388 crossref_primary_10_1016_j_foodhyd_2023_109427 crossref_primary_10_3390_polym17030365 crossref_primary_10_1186_s42269_024_01236_9 crossref_primary_10_2147_DDDT_S499068 crossref_primary_10_1016_j_eurpolymj_2024_113358 crossref_primary_10_3390_molecules30040962 crossref_primary_10_1016_j_jddst_2024_106377 crossref_primary_10_3390_ijms241612827 crossref_primary_10_3390_pharmaceutics16050588 crossref_primary_10_3390_pharmaceutics15030768 crossref_primary_10_3389_fbioe_2024_1499474 crossref_primary_10_3390_jox15010008 crossref_primary_10_1016_j_bioorg_2023_106550 crossref_primary_10_1021_acsptsci_4c00462 crossref_primary_10_3390_pharmaceutics14122658 crossref_primary_10_3390_pharmaceutics16091172 crossref_primary_10_3390_molecules28072969 crossref_primary_10_1002_slct_202402903 crossref_primary_10_1007_s11051_025_06238_w crossref_primary_10_3390_gels10010039 crossref_primary_10_1063_5_0214899 crossref_primary_10_1016_j_ijpharm_2024_124024 crossref_primary_10_1002_biot_202400379 crossref_primary_10_3390_pharmaceutics16081011 crossref_primary_10_1002_smll_202301113 crossref_primary_10_1016_j_jddst_2023_104910 crossref_primary_10_1208_s12249_023_02611_x crossref_primary_10_3390_jfb15080209 crossref_primary_10_1039_D2SM01447E crossref_primary_10_1177_15593258241264951 crossref_primary_10_3390_brainsci14010082 crossref_primary_10_1016_j_apmt_2024_102570 crossref_primary_10_1016_j_eurpolymj_2024_113244 crossref_primary_10_3389_fchem_2023_1044953 crossref_primary_10_3390_pharmaceutics15030879 crossref_primary_10_1016_j_eurpolymj_2025_113740 crossref_primary_10_4103_1735_5362_394820 crossref_primary_10_1016_j_jddst_2024_106380 crossref_primary_10_3389_fphar_2024_1482130 crossref_primary_10_3390_ph17050625 crossref_primary_10_1186_s43094_024_00727_w crossref_primary_10_2174_1389200223666220627110049 crossref_primary_10_1016_j_addr_2023_114871 crossref_primary_10_1016_j_ceramint_2024_05_403 crossref_primary_10_1002_ptr_8334 crossref_primary_10_3390_polym15173558 crossref_primary_10_1016_j_matpr_2022_06_003 crossref_primary_10_1016_j_drudis_2023_103849 crossref_primary_10_26565_2312_4334_2024_4_54 crossref_primary_10_3390_molecules29235654 crossref_primary_10_1016_j_ejmcr_2024_100206 crossref_primary_10_1016_j_mtbio_2024_101423 crossref_primary_10_1021_acsami_3c16544 crossref_primary_10_1021_acsapm_3c00221 crossref_primary_10_1039_D3NJ01822A crossref_primary_10_1016_j_surfin_2024_104037 crossref_primary_10_3390_pharmaceutics15112605 crossref_primary_10_1007_s11696_023_03263_8 crossref_primary_10_1016_j_ijbiomac_2023_123151 crossref_primary_10_1515_ntrev_2023_0218 crossref_primary_10_3390_bioengineering11060573 crossref_primary_10_1016_j_eurpolymj_2025_113773 crossref_primary_10_3390_ph17121738 crossref_primary_10_1002_mabi_202400150 crossref_primary_10_1016_j_carbpol_2023_121258 crossref_primary_10_3390_ijms251910766 crossref_primary_10_2147_IJN_S413831 crossref_primary_10_1002_advs_202407850 crossref_primary_10_3390_ijms241411869 crossref_primary_10_35812_CelluloseChemTechnol_2023_57_47 crossref_primary_10_2147_IJN_S410688 crossref_primary_10_1016_j_ijpharm_2022_122504 crossref_primary_10_1016_j_micpath_2024_107083 crossref_primary_10_3390_ijms25116147 crossref_primary_10_47162_RJME_65_2_01 crossref_primary_10_1007_s44174_024_00211_2 crossref_primary_10_1016_j_hsr_2025_100212 crossref_primary_10_1021_acs_jced_4c00407 crossref_primary_10_1186_s13065_024_01138_x crossref_primary_10_1002_mabi_202400273 crossref_primary_10_1016_j_procbio_2023_04_005 crossref_primary_10_1021_acsami_4c02462 crossref_primary_10_1007_s44174_025_00277_6 crossref_primary_10_3389_fonc_2022_1042125 crossref_primary_10_1016_j_ijpharm_2024_124163 crossref_primary_10_3390_fib11020021 crossref_primary_10_1002_pca_3440 crossref_primary_10_1016_j_eurpolymj_2024_113467 crossref_primary_10_1186_s11671_024_04149_8 crossref_primary_10_3390_ph16060777 crossref_primary_10_2174_0124522716311647240613050008 crossref_primary_10_1002_advs_202403388 crossref_primary_10_3390_gels11010015 crossref_primary_10_3390_pharmaceutics16050674 crossref_primary_10_3390_nano15060415 crossref_primary_10_2174_1389557523666230913105803 crossref_primary_10_1021_acsabm_3c00776 crossref_primary_10_1021_acsapm_4c01765 crossref_primary_10_1208_s12249_024_02982_9 crossref_primary_10_1016_j_addr_2023_114853 crossref_primary_10_1016_j_ijbiomac_2024_133590 crossref_primary_10_1021_acsanm_3c00705 crossref_primary_10_3390_ma17235816 crossref_primary_10_1016_j_medidd_2025_100205 crossref_primary_10_1021_acs_jmedchem_3c01884 crossref_primary_10_1016_j_carpta_2025_100670 crossref_primary_10_1186_s13065_024_01200_8 crossref_primary_10_3390_ph17091110 crossref_primary_10_3390_pharmaceutics15082126 crossref_primary_10_1016_j_eurpolymj_2024_112983 crossref_primary_10_1002_pat_70050 crossref_primary_10_1080_1061186X_2023_2300690 crossref_primary_10_13005_bbra_3329 crossref_primary_10_1016_j_eurpolymj_2023_112105 crossref_primary_10_1016_j_biopha_2023_115353 crossref_primary_10_1016_j_jddst_2024_106173 crossref_primary_10_2174_0118764029286890240314060427 crossref_primary_10_1021_acs_inorgchem_2c00743 crossref_primary_10_1021_acs_analchem_3c05079 crossref_primary_10_1021_acsmacrolett_3c00668 crossref_primary_10_1186_s42269_024_01220_3 crossref_primary_10_1016_j_ijpharm_2023_123414 crossref_primary_10_1021_acs_langmuir_4c00797 crossref_primary_10_3390_ijms23084458 crossref_primary_10_1016_j_addr_2025_115519 crossref_primary_10_1080_17425247_2024_2412826 crossref_primary_10_1007_s00289_024_05245_6 crossref_primary_10_3390_pharmaceutics16030423 crossref_primary_10_1039_D3TB02292G crossref_primary_10_3389_fbioe_2024_1515164 crossref_primary_10_3389_fonc_2025_1526718 crossref_primary_10_1016_j_carpta_2023_100389 crossref_primary_10_1007_s10522_025_10189_z crossref_primary_10_1080_00914037_2023_2277235 crossref_primary_10_1515_mr_2023_0058 crossref_primary_10_3390_pharmaceutics15061631 crossref_primary_10_47836_pjst_32_2_14 crossref_primary_10_1002_ange_202417075 crossref_primary_10_1208_s12249_024_02905_8 crossref_primary_10_1016_j_jddst_2025_106681 crossref_primary_10_1021_acs_langmuir_4c03953 crossref_primary_10_1016_j_ejpb_2024_114334 crossref_primary_10_1007_s44174_023_00118_4 crossref_primary_10_1002_jbm_a_37839 crossref_primary_10_1016_j_ijpharm_2023_123642 crossref_primary_10_1155_2024_5081655 crossref_primary_10_1016_j_ijpharm_2023_123765 crossref_primary_10_1007_s10876_024_02691_0 crossref_primary_10_1039_D4PM00009A crossref_primary_10_1080_01932691_2024_2334012 crossref_primary_10_3390_polym14020227 crossref_primary_10_1007_s44246_023_00066_0 crossref_primary_10_3390_lipidology1020010 crossref_primary_10_3390_jfb15070180 crossref_primary_10_3390_pharmaceutics16121568 crossref_primary_10_1016_j_carpta_2023_100373 crossref_primary_10_1007_s10856_024_06857_0 crossref_primary_10_1016_j_heliyon_2023_e17488 crossref_primary_10_15671_hjbc_1530114 crossref_primary_10_2147_DDDT_S448807 crossref_primary_10_1016_j_jddst_2024_106394 crossref_primary_10_1080_10837450_2023_2233588 crossref_primary_10_1515_ntrev_2024_0023 crossref_primary_10_1080_17435889_2025_2457781 crossref_primary_10_70401_bmeh_2024_136 crossref_primary_10_1016_j_eurpolymj_2023_112206 crossref_primary_10_1016_j_ijbiomac_2024_134402 crossref_primary_10_22159_ijap_2024v16i3_50298 crossref_primary_10_1016_j_heliyon_2024_e40547 crossref_primary_10_2174_0113816128338560240923073357 crossref_primary_10_1039_D4TC01229A crossref_primary_10_1002_adtp_202400189 crossref_primary_10_1016_j_ijpharm_2023_122587 crossref_primary_10_1016_j_heliyon_2022_e12634 crossref_primary_10_4103_jcsr_jcsr_174_23 crossref_primary_10_3390_polym15040971 crossref_primary_10_1016_j_molliq_2023_123888 crossref_primary_10_1016_j_colsurfa_2022_129343 crossref_primary_10_1126_sciadv_adn2332 crossref_primary_10_1016_j_heliyon_2024_e36297 crossref_primary_10_1016_j_surfin_2024_105576 crossref_primary_10_1007_s10924_024_03451_x crossref_primary_10_1111_dom_15759 crossref_primary_10_33084_bjop_v6i2_3155 crossref_primary_10_1039_D4RA03359K crossref_primary_10_1111_odi_14928 crossref_primary_10_3390_ma16196431 crossref_primary_10_1002_smll_202410844 crossref_primary_10_1016_j_ijpharm_2022_122279 crossref_primary_10_1371_journal_pone_0306140 crossref_primary_10_1016_j_gendis_2024_101402 crossref_primary_10_1016_j_jics_2024_101125 crossref_primary_10_3390_md22020080 crossref_primary_10_1134_S2634827624600312 crossref_primary_10_1016_j_ijbiomac_2023_125472 crossref_primary_10_1002_pat_70086 crossref_primary_10_1007_s42823_024_00702_8 crossref_primary_10_4236_anp_2024_133004 crossref_primary_10_1021_acsomega_3c07356 crossref_primary_10_1016_j_ymeth_2024_12_008 crossref_primary_10_3390_ijms241411686 crossref_primary_10_1016_j_ijpharm_2025_125484 crossref_primary_10_1038_s41573_023_00670_0 crossref_primary_10_3390_pharmaceutics15030920 crossref_primary_10_1016_j_afres_2022_100225 crossref_primary_10_1002_wnan_1984 crossref_primary_10_3389_fncel_2024_1485427 crossref_primary_10_1016_j_ejpb_2024_114526 crossref_primary_10_1016_j_jddst_2023_104519 crossref_primary_10_3390_su16198439 crossref_primary_10_1016_j_colsurfa_2024_133571 crossref_primary_10_1039_D3GC04183B crossref_primary_10_3390_polym17060781 crossref_primary_10_1590_1980_5373_mr_2022_0492 crossref_primary_10_1016_j_addr_2022_114622 crossref_primary_10_3390_ma17225415 crossref_primary_10_1007_s10856_024_06802_1 crossref_primary_10_3390_pharmaceutics16081095 crossref_primary_10_1016_j_addr_2024_115395 crossref_primary_10_1002_app_52753 crossref_primary_10_1016_j_ejps_2022_106363 crossref_primary_10_1080_00914037_2023_2235872 crossref_primary_10_1016_j_ijpharm_2025_125370 crossref_primary_10_1016_j_ejps_2023_106501 crossref_primary_10_1007_s13346_023_01411_x crossref_primary_10_1016_j_ijbiomac_2024_133526 crossref_primary_10_1080_25740881_2024_2440531 crossref_primary_10_3390_ijms232214467 crossref_primary_10_3389_fphar_2023_1263834 crossref_primary_10_1002_wnan_1995 crossref_primary_10_1080_09276440_2024_2331329 crossref_primary_10_3390_biom13071085 crossref_primary_10_1002_wnan_1996 crossref_primary_10_1016_j_xphs_2024_01_003 crossref_primary_10_1021_acs_jpclett_4c01894 crossref_primary_10_1002_EXP_20220132 crossref_primary_10_3390_gels10100625 crossref_primary_10_3390_polym16020206 crossref_primary_10_1007_s13346_023_01311_0 crossref_primary_10_1016_j_ijpharm_2023_123724 crossref_primary_10_1080_02652048_2024_2404414 crossref_primary_10_1016_j_intimp_2025_114350 crossref_primary_10_1177_19476035241240361 crossref_primary_10_2174_0122103031304556240430161553 crossref_primary_10_1016_j_ultras_2025_107611 crossref_primary_10_1371_journal_pone_0313523 crossref_primary_10_1007_s44371_025_00133_y crossref_primary_10_1007_s40005_024_00684_9 crossref_primary_10_1016_j_addr_2024_115386 crossref_primary_10_1016_j_inoche_2025_113979 crossref_primary_10_1002_cben_202300027 crossref_primary_10_33609_2708_129X_89_11_2023_64_74 crossref_primary_10_16984_saufenbilder_1137591 crossref_primary_10_1016_j_ijbiomac_2023_128525 crossref_primary_10_1186_s12943_024_02163_z crossref_primary_10_1111_cbdd_14580 crossref_primary_10_1007_s12668_024_01683_8 crossref_primary_10_1016_j_ijbiomac_2024_132302 crossref_primary_10_1016_j_jconrel_2023_12_008 crossref_primary_10_7759_cureus_80547 crossref_primary_10_3390_ijms23084118 crossref_primary_10_1016_j_ejpb_2024_114623 crossref_primary_10_1080_15583724_2023_2262542 crossref_primary_10_1016_j_ijbiomac_2024_131694 crossref_primary_10_1016_j_matchemphys_2024_129836 crossref_primary_10_1007_s10570_024_06109_y crossref_primary_10_1021_acsami_4c06661 crossref_primary_10_3390_cells12192387 crossref_primary_10_7759_cureus_69556 crossref_primary_10_2174_0122106812276945231201071629 crossref_primary_10_1016_j_addr_2024_115179 crossref_primary_10_1016_j_jconrel_2024_07_017 crossref_primary_10_1016_j_colsurfa_2024_133556 crossref_primary_10_1016_j_jddst_2023_104733 crossref_primary_10_3389_fbioe_2023_1190171 crossref_primary_10_1002_psc_3662 crossref_primary_10_1016_j_jece_2024_115133 crossref_primary_10_3390_pharmaceutics15061718 crossref_primary_10_1016_j_ejpb_2024_114513 crossref_primary_10_1016_j_ijpharm_2023_122777 crossref_primary_10_3390_polym14183736 crossref_primary_10_1016_j_heliyon_2024_e33703 crossref_primary_10_1002_adfm_202310129 crossref_primary_10_1039_D4RA00352G crossref_primary_10_3390_polym15173494 crossref_primary_10_1002_pat_6317 crossref_primary_10_1016_j_ijpharm_2023_123742 crossref_primary_10_1007_s13233_023_00171_4 crossref_primary_10_4103_jos_jos_3_24 crossref_primary_10_1002_anie_202417075 crossref_primary_10_1177_09544119231162772 crossref_primary_10_1039_D2MA01075E crossref_primary_10_1038_s41598_024_80596_8 crossref_primary_10_3390_polym16131890 crossref_primary_10_1016_j_apsadv_2024_100665 crossref_primary_10_1109_TBME_2023_3340613 crossref_primary_10_1021_acsomega_3c06745 crossref_primary_10_1016_j_critrevonc_2023_103980 crossref_primary_10_1039_D4SM00782D crossref_primary_10_1002_masy_202300141 crossref_primary_10_1016_j_jddst_2023_104311 crossref_primary_10_1016_j_jddst_2023_104432 crossref_primary_10_1021_acsanm_4c03657 crossref_primary_10_1002_adem_202301297 crossref_primary_10_2174_2210681212666220707141136 crossref_primary_10_22159_ijap_2025v17i2_53177 crossref_primary_10_3390_pharmaceutics17030355 crossref_primary_10_1016_j_mtbio_2023_100837 crossref_primary_10_2174_2667387817666230119103126 crossref_primary_10_1016_j_ijbiomac_2024_134817 crossref_primary_10_1016_j_lfs_2024_122635 crossref_primary_10_3390_antiox13091030 crossref_primary_10_1016_j_ijbiomac_2024_131666 crossref_primary_10_3390_pharmaceutics15102431 crossref_primary_10_1080_17425247_2023_2237408 crossref_primary_10_3762_bjnano_15_88 crossref_primary_10_1016_j_rechem_2024_101695 crossref_primary_10_1039_D2TB00608A crossref_primary_10_1142_S1793292024300111 crossref_primary_10_1080_20415990_2024_2394012 crossref_primary_10_3389_fmed_2024_1463976 crossref_primary_10_1016_j_carres_2024_109199 crossref_primary_10_1016_j_ijpharm_2022_121921 crossref_primary_10_3390_ph16071038 crossref_primary_10_1186_s42252_024_00063_5 crossref_primary_10_33920_med_13_2202_06 crossref_primary_10_1016_j_ijpharm_2024_124991 crossref_primary_10_1007_s00210_023_02714_z crossref_primary_10_1016_j_ejmech_2023_115994 crossref_primary_10_3390_ph17030271 crossref_primary_10_1007_s11051_024_06013_3 crossref_primary_10_1080_1061186X_2024_2449486 crossref_primary_10_1556_650_2024_33116 crossref_primary_10_1021_acsami_4c16261 crossref_primary_10_1016_j_heliyon_2023_e16674 crossref_primary_10_1038_s41598_024_61278_x crossref_primary_10_1002_slct_202402048 crossref_primary_10_3390_coatings13071273 crossref_primary_10_3389_fnins_2024_1330470 crossref_primary_10_3390_bioengineering10070804 crossref_primary_10_3390_molecules29112584 crossref_primary_10_3390_pharmaceutics16070852 crossref_primary_10_3897_pharmacia_71_e126316 crossref_primary_10_1016_j_ijbiomac_2024_139144 crossref_primary_10_3390_md21070420 crossref_primary_10_1007_s12033_024_01195_6 crossref_primary_10_3390_app14041383 crossref_primary_10_1016_j_ceramint_2024_10_194 crossref_primary_10_1590_s2175_97902025e24249 crossref_primary_10_1080_10717544_2023_2180113 crossref_primary_10_2174_0109298673268775231003111540 crossref_primary_10_1007_s00259_024_07014_z crossref_primary_10_1016_j_jddst_2023_104893 crossref_primary_10_3389_fbioe_2022_969843 crossref_primary_10_1016_j_apmt_2024_102194 crossref_primary_10_3390_molecules29194629 crossref_primary_10_1016_j_rechem_2023_101053 crossref_primary_10_22270_jddt_v15i1_6936 crossref_primary_10_3390_app14010169 crossref_primary_10_54994_emujpharmsci_1215120 crossref_primary_10_1021_acs_chemmater_3c00303 crossref_primary_10_1016_j_ijbiomac_2024_139011 crossref_primary_10_1016_j_nwnano_2023_100025 crossref_primary_10_1021_acsabm_3c00178 crossref_primary_10_1002_smll_202400771 crossref_primary_10_1007_s13206_022_00072_1 crossref_primary_10_1134_S0003683822060059 crossref_primary_10_1002_adtp_202400239 crossref_primary_10_1016_j_mseb_2023_116816 crossref_primary_10_3390_inorganics13040098 crossref_primary_10_1016_j_cis_2024_103121 crossref_primary_10_3390_molecules30020252 crossref_primary_10_1007_s12668_024_01374_4 crossref_primary_10_1016_j_comptc_2023_114411 crossref_primary_10_1016_j_csite_2023_102764 crossref_primary_10_1016_j_jddst_2023_104886 crossref_primary_10_1016_j_carbpol_2025_123454 crossref_primary_10_1007_s12247_022_09647_9 crossref_primary_10_1016_j_carbpol_2024_123174 crossref_primary_10_3390_bioengineering10010003 crossref_primary_10_3390_antibiotics12061073 crossref_primary_10_1002_ppsc_202400049 crossref_primary_10_1016_j_cclet_2024_109527 crossref_primary_10_1109_TPS_2024_3513560 crossref_primary_10_3390_pharmaceutics15010001 crossref_primary_10_1016_j_medidd_2022_100134 crossref_primary_10_3389_fnut_2022_950823 crossref_primary_10_1021_acs_bioconjchem_4c00255 crossref_primary_10_1016_j_addr_2023_115157 crossref_primary_10_1007_s10904_025_03616_8 crossref_primary_10_1016_j_colsurfb_2024_114012 crossref_primary_10_1016_j_jddst_2024_105607 crossref_primary_10_1007_s12247_024_09808_y crossref_primary_10_2147_IJN_S475742 crossref_primary_10_1615_NanoSciTechnolIntJ_2022043749 crossref_primary_10_3390_pharmaceutics16070921 crossref_primary_10_1016_j_carbpol_2024_123043 crossref_primary_10_3389_fmats_2025_1534127 crossref_primary_10_1016_j_jconrel_2024_06_071 crossref_primary_10_1007_s40840_025_01827_3 crossref_primary_10_1016_j_aca_2024_343341 crossref_primary_10_1016_j_rechem_2024_101772 crossref_primary_10_1007_s13233_023_00191_0 crossref_primary_10_3390_polym16091182 crossref_primary_10_1016_j_rechem_2024_101414 crossref_primary_10_1089_adt_2023_042 crossref_primary_10_3390_ph16101360 crossref_primary_10_1016_j_molliq_2024_124383 crossref_primary_10_3390_cells11213445 crossref_primary_10_3390_ijms25084386 crossref_primary_10_1002_adem_202400563 crossref_primary_10_3390_gels10110693 crossref_primary_10_1016_j_heliyon_2024_e36038 crossref_primary_10_1208_s12249_023_02682_w crossref_primary_10_1080_17425247_2024_2448026 crossref_primary_10_1002_adfm_202212952 crossref_primary_10_1002_cbdv_202301157 crossref_primary_10_1016_j_aej_2025_02_099 crossref_primary_10_3389_fmicb_2023_1339303 crossref_primary_10_1039_D4PM00085D crossref_primary_10_1016_j_comptc_2024_114884 crossref_primary_10_1016_j_ejpb_2024_114343 crossref_primary_10_1080_09205063_2024_2362023 crossref_primary_10_1155_2022_6048280 crossref_primary_10_1016_j_jddst_2023_105308 crossref_primary_10_1016_j_arabjc_2022_104533 crossref_primary_10_1016_j_jsps_2024_102046 crossref_primary_10_1016_j_jconrel_2023_10_042 crossref_primary_10_1016_j_jddst_2024_105822 crossref_primary_10_1002_bab_2719 crossref_primary_10_3390_gels8090594 crossref_primary_10_3390_ijms25020786 crossref_primary_10_3390_pharmaceutics17030375 crossref_primary_10_1007_s43440_023_00510_3 crossref_primary_10_1016_j_fitote_2024_106222 crossref_primary_10_1038_s41598_023_41572_w crossref_primary_10_3390_jcs8070282 crossref_primary_10_1021_acsbiomaterials_3c00710 crossref_primary_10_3390_pharmaceutics15041052 crossref_primary_10_3390_nano14191598 crossref_primary_10_1016_j_molliq_2025_126999 crossref_primary_10_1021_acsabm_4c01052 crossref_primary_10_1021_acsanm_3c04631 crossref_primary_10_1002_anbr_202300041 crossref_primary_10_1021_acsami_4c11855 crossref_primary_10_1080_17434440_2023_2244875 crossref_primary_10_3390_pharmaceutics15071917 crossref_primary_10_1016_j_reactfunctpolym_2024_105826
Cites_doi	10.1016/S1359-0294(00)00090-X 10.1039/D0RA03491F 10.1007/978-1-4939-9798-5_1 10.1038/nprot.2007.303 10.1126/science.2218494 10.1038/natrevmats.2016.71 10.1016/j.jddst.2020.101855 10.1016/j.jconrel.2015.10.005 10.3390/ijms22115433 10.1002/marc.201800917 10.1039/D0NR04102E 10.1007/978-1-4614-0881-9 10.3389/fphar.2019.01650 10.3389/fbioe.2019.00489 10.2147/IJN.S138624 10.1016/S1056-8719(00)00110-6 10.5772/61160 10.5772/intechopen.93368 10.2147/IJN.S299448 10.1016/j.polymer.2008.01.027 10.2174/1871527319666200916121515 10.3390/pharmaceutics11110591 10.1016/B978-0-12-817909-3.00001-7 10.1016/j.jddst.2019.03.038 10.1111/j.1749-6632.1991.tb27239.x 10.1039/C4TB00171K 10.1016/B978-012369417-1/50058-4 10.3390/nano11081968 10.3390/md15040096 10.1002/adma.201705328 10.1007/s41403-020-00192-w 10.1002/smll.201903060 10.1080/00914037.2019.1655753 10.1002/9780470640487.ch15 10.3109/10717544.2014.913733 10.1016/j.jconrel.2014.03.054 10.3390/molecules25235649 10.1002/wnan.1678 10.3390/pharmaceutics12090876 10.1016/j.ijpharm.2017.03.017 10.1007/s43538-021-00012-x 10.1016/j.ijpharm.2005.01.005 10.1016/j.drudis.2020.06.006 10.1016/B978-0-12-369521-5.00009-9 10.1021/acs.macromol.1c00010 10.1016/j.biomaterials.2020.119987 10.1016/j.jconrel.2011.10.006 10.1039/D0RA04316H 10.3390/polym10101098 10.1016/j.apsusc.2017.07.197 10.1002/9781119711698.ch5 10.3390/molecules26092797 10.1111/j.1749-6632.1971.tb46890.x 10.2165/00003088-199936030-00004 10.3389/conf.FBIOE.2016.01.00807 10.1016/S1359-0294(98)80036-8 10.1016/S0144-8617(99)00104-6 10.1007/978-3-662-49320-5_25 10.3390/molecules25173982 10.1039/C9TB02052G 10.3390/molecules23010047 10.1016/j.jconrel.2019.07.004 10.1208/s12248-008-9020-0 10.2217/nnm-2018-0088 10.1039/C5PY00998G 10.2174/187221107782331638 10.18433/J38W25 10.1016/j.jconrel.2020.02.022 10.1016/j.jddst.2021.102426 10.3390/pharmaceutics13030357 10.1369/0022155411398487 10.1038/nbt.1504 10.1080/17425247.2019.1660318 10.1021/acs.biomac.9b01009 10.1201/9781420008449 10.1039/C6TB00049E 10.1021/nn203430m 10.3390/s19061279 10.1016/B978-0-12-816137-1.00078-7 10.1016/j.colsurfb.2013.05.018 10.20944/preprints201810.0507.v1 10.4155/tde-2016-0060 10.1111/jphp.13098 10.2174/1567201815666180723114326 10.1016/j.carbpol.2017.08.133 10.1016/j.mtla.2020.100585 10.1158/0008-5472.CAN-12-1683 10.1038/s42003-020-0817-4 10.3389/fphar.2019.00010 10.1093/jpp/rgab102 10.1038/s41598-017-11533-1 10.2174/1566523220999200731011702 10.1038/nrd4363 10.1007/s10311-018-00841-1 10.7150/thno.52570 10.1016/j.actbio.2019.03.057 10.3390/fluids3040074 10.1016/j.cobme.2021.100311 10.1021/acs.biomac.8b00057 10.1016/j.carbpol.2020.116816 10.1016/j.polymer.2020.122993 10.1016/j.ijbiomac.2017.11.163 10.1002/9780470259818.ch9 10.3389/fphar.2015.00286 10.3109/1061186X.2010.526227 10.1186/s12951-018-0392-8 10.1016/B978-0-12-814031-4.00005-2 10.1201/9781315102856 10.1201/b15115 10.1016/j.addr.2012.10.014 10.1016/j.biomaterials.2017.04.022 10.1039/9781788013536-00001 10.1016/j.addr.2012.09.037 10.1016/j.actbio.2018.03.018 10.1038/s41467-020-17029-3 10.1016/j.drudis.2020.07.007 10.2478/acph-2019-0016 10.1038/nrd1304 10.1002/jps.20477 10.1080/17435390.2020.1771785 10.1088/1748-6041/4/2/022001 10.3390/molecules23040938 10.1155/2008/469531 10.3389/fchem.2018.00619 10.1016/j.jconrel.2014.05.029 10.4103/2230-973X.160844 10.2174/092986706778201648 10.1186/s12951-018-0403-9 10.1016/j.addr.2018.10.017
ContentType	Journal Article
Copyright	2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021
Copyright_xml	– notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021
DBID	AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA
DOI	10.3390/molecules26195905
DatabaseName	CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text
DatabaseTitle	CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Publicly Available Content Database CrossRef
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Chemistry
EISSN	1420-3049
ExternalDocumentID	oai_doaj_org_article_cb3c9c1d7d8840b2ae220674723df898 PMC8512302 10_3390_molecules26195905
GroupedDBID	--- 0R~ 123 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIWK ACPRK ACUHS AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESX FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE HZ~ I09 IAO IHR ITC KQ8 LK8 M1P MODMG O-U O9- OK1 P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RPM SV3 TR2 TUS UKHRP ~8M 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO
ID	FETCH-LOGICAL-c470t-11ddf4712de1902d048dcd2cb3b68f3f28c5bcc2b74d021842b3f17113a8e41c3
IEDL.DBID	7X7
ISSN	1420-3049
IngestDate	Wed Aug 27 01:25:25 EDT 2025 Thu Aug 21 13:33:50 EDT 2025 Fri Jul 11 11:47:02 EDT 2025 Fri Jul 25 20:00:36 EDT 2025 Thu Apr 24 22:54:33 EDT 2025 Tue Jul 01 03:11:58 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	19
Language	English
License	https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c470t-11ddf4712de1902d048dcd2cb3b68f3f28c5bcc2b74d021842b3f17113a8e41c3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
ORCID	0000-0003-0784-1120 0000-0001-8479-8686
OpenAccessLink	https://www.proquest.com/docview/2580993735?pq-origsite=%requestingapplication%
PMID	34641447
PQID	2580993735
PQPubID	2032355
ParticipantIDs	doaj_primary_oai_doaj_org_article_cb3c9c1d7d8840b2ae220674723df898 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8512302 proquest_miscellaneous_2581824201 proquest_journals_2580993735 crossref_primary_10_3390_molecules26195905 crossref_citationtrail_10_3390_molecules26195905
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	20210929
PublicationDateYYYYMMDD	2021-09-29
PublicationDate_xml	– month: 9 year: 2021 text: 20210929 day: 29
PublicationDecade	2020
PublicationPlace	Basel
PublicationPlace_xml	– name: Basel
PublicationTitle	Molecules (Basel, Switzerland)
PublicationYear	2021
Publisher	MDPI AG MDPI
Publisher_xml	– name: MDPI AG – name: MDPI
References	Price (ref_140) 2018; 6 Sercombe (ref_77) 2015; 6 Bartucci (ref_168) 2020; 14 ref_14 Allen (ref_16) 2014; 18 ref_12 ref_11 ref_10 ref_133 ref_132 Wei (ref_176) 2020; 11 Patra (ref_86) 2018; 16 ref_135 ref_134 Kocbek (ref_92) 2019; 51 Attia (ref_75) 2019; 71 Liang (ref_84) 2021; 11 Ghaderi (ref_129) 2011; 19 Shahriari (ref_150) 2019; 308 Hou (ref_165) 2020; 12 Monteiro (ref_148) 2021; 13 ref_128 Li (ref_112) 2020; 210 Yun (ref_63) 2015; 219 Hubatsch (ref_33) 2007; 2 ref_21 Adepu (ref_94) 2017; 426 ref_121 Kumar (ref_24) 2016; 5 Adepu (ref_89) 2020; 9 Barroso (ref_131) 2011; 59 ref_29 Mi (ref_109) 2000; 41 Preeti (ref_177) 2021; 11 Datta (ref_137) 2018; 19 Shah (ref_76) 2021; 13 Madani (ref_104) 2011; 6 Trenfield (ref_179) 2019; 16 Kumar (ref_57) 2007; 1 Tu (ref_159) 2019; 90 Patil (ref_56) 2018; 9 Mahalingam (ref_15) 2008; 1 Yang (ref_145) 2019; 10 Habet (ref_45) 2021; 73 ref_151 Bunggulawa (ref_85) 2018; 16 Srikonda (ref_55) 2006; 1 ref_154 Patel (ref_6) 2011; 2 ref_73 ref_156 Rai (ref_143) 2016; 23 Yadav (ref_80) 2017; 7 Jain (ref_157) 2015; 6 Singh (ref_155) 2018; 110 Zare (ref_93) 2020; 4 Geiselhart (ref_149) 2021; 54 Zhao (ref_163) 2016; 4 Alex (ref_101) 2017; 133 Verma (ref_9) 2010; 1 ref_83 Zhao (ref_153) 2019; 15 Chaudhari (ref_4) 2012; 1 ref_82 ref_147 Farokhi (ref_98) 2020; 321 Khan (ref_19) 2019; 69 ref_142 Natarajan (ref_71) 2014; 193 ref_87 Jain (ref_5) 2020; 2059 Naz (ref_74) 2021; 20 Lu (ref_169) 2020; 245 Langer (ref_3) 1990; 249 Li (ref_108) 2016; 1 Manzoor (ref_116) 2012; 72 Adepu (ref_96) 2021; 6 Zhao (ref_166) 2013; 8 Prausnitz (ref_18) 2004; 3 Adepu (ref_97) 2020; 249 Tayeb (ref_107) 2018; 13 Dhiman (ref_20) 2011; 3 Agarwal (ref_122) 2020; 20 Singh (ref_49) 2019; 4 ref_58 ref_173 ref_172 ref_175 Gillette (ref_37) 1971; 179 Payne (ref_27) 2002; 49 ref_53 Adepu (ref_95) 2021; 87 Qu (ref_162) 2018; 72 ref_52 Mitragotri (ref_50) 2014; 13 Langer (ref_1) 1998; 392 Zaidi (ref_174) 2020; 3 Cao (ref_158) 2019; 20 ref_59 Dimov (ref_79) 2017; 7 Ge (ref_161) 2012; 6 Alyassin (ref_124) 2020; 25 Zare (ref_103) 2021; 16 (ref_28) 2011; 11 Gad (ref_22) 2008; Volume 5 ref_61 ref_60 Deng (ref_70) 2020; 7 Shubhika (ref_115) 2012; 5 ref_68 ref_164 ref_65 ref_64 Caminade (ref_81) 2014; 2 Cai (ref_138) 2020; 10 Doberenz (ref_160) 2020; 8 ref_167 Ku (ref_8) 2008; 10 Desai (ref_123) 2021; 18 Reinberg (ref_40) 1991; 618 Timur (ref_126) 2020; 69 Barenholz (ref_117) 2001; 6 Zou (ref_114) 2020; 10 ref_171 ref_170 Muraca (ref_90) 2020; 7 Duan (ref_91) 2020; 10 Bharti (ref_125) 2015; 5 Prausnitz (ref_17) 2008; 26 Gibot (ref_139) 2019; 138 ref_119 Paarakh (ref_44) 2018; 8 ref_118 Matea (ref_130) 2017; 12 Amukarimi (ref_141) 2021; 19 Deirram (ref_144) 2019; 40 ref_36 ref_35 ref_34 Fenton (ref_48) 2018; 30 Hoare (ref_110) 2008; 49 ref_30 ref_113 Siepmann (ref_54) 2012; 161 Vaidya (ref_120) 2018; 8 ref_39 (ref_99) 2018; 15 Adepu (ref_88) 2018; 53 Linsley (ref_152) 2017; 8 Beg (ref_178) 2020; 25 Saleemi (ref_102) 2020; 59 Obata (ref_32) 2005; 293 Li (ref_106) 2017; 524 Bilensoy (ref_127) 2018; 12 Neuse (ref_66) 2008; 2008 Gupta (ref_51) 2010; 13 Kalasz (ref_7) 2006; 13 Mortensen (ref_100) 1998; 3 ref_105 Srivastava (ref_67) 2015; 4 ref_46 Sears (ref_26) 1951; 166 Bora (ref_13) 2014; 5 Londono (ref_23) 2008; Volume 5 ref_43 ref_42 Wei (ref_111) 2017; 177 Kalantzi (ref_25) 2006; 95 ref_41 Allen (ref_78) 2013; 65 Chamundeeswari (ref_72) 2019; 17 Fleisher (ref_31) 1999; 36 ref_2 Ekins (ref_38) 2000; 44 Park (ref_47) 2014; 190 Bawa (ref_69) 2009; 4 (ref_62) 2013; 65 Palanikumar (ref_136) 2020; 3 Vivek (ref_146) 2013; 111
References_xml	– volume: 6 start-page: 66 year: 2001 ident: ref_117 article-title: Liposome application: Problems and prospects publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/S1359-0294(00)00090-X – volume: 10 start-page: 26777 year: 2020 ident: ref_91 article-title: A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems publication-title: RSC Adv. doi: 10.1039/D0RA03491F – volume: 2059 start-page: 1 year: 2020 ident: ref_5 article-title: An overview of drug delivery systems publication-title: Drug Deliv. Syst. doi: 10.1007/978-1-4939-9798-5_1 – volume: 2 start-page: 2111 year: 2007 ident: ref_33 article-title: Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers publication-title: Nat. Protoc. doi: 10.1038/nprot.2007.303 – volume: 249 start-page: 1527 year: 1990 ident: ref_3 article-title: New methods of drug delivery publication-title: Science doi: 10.1126/science.2218494 – ident: ref_68 – volume: 1 start-page: 16071 year: 2016 ident: ref_108 article-title: Designing hydrogels for controlled drug delivery publication-title: Nat. Rev. Mater. doi: 10.1038/natrevmats.2016.71 – volume: 59 start-page: 101855 year: 2020 ident: ref_102 article-title: An overview of recent development in therapeutic drug carrier system using carbon nanotubes publication-title: J. Drug Deliv. Sci. Technol. doi: 10.1016/j.jddst.2020.101855 – volume: 219 start-page: 2 year: 2015 ident: ref_63 article-title: Controlled drug delivery: Historical perspective for the next generation publication-title: J. Control. Release doi: 10.1016/j.jconrel.2015.10.005 – ident: ref_42 – ident: ref_87 doi: 10.3390/ijms22115433 – volume: 40 start-page: 1800917 year: 2019 ident: ref_144 article-title: pH-Responsive Polymer Nanoparticles for Drug Delivery publication-title: Macromol. Rapid Commun. doi: 10.1002/marc.201800917 – volume: 12 start-page: 23824 year: 2020 ident: ref_165 article-title: Electrochemically controlled cleavage of imine bonds on a graphene platform: Towards new electro-responsive hybrids for drug release publication-title: Nanoscale doi: 10.1039/D0NR04102E – volume: 11 start-page: 26 year: 2011 ident: ref_28 article-title: Using gargles and mouthwashes: Medicine cupboard publication-title: SA Pharm. Assist. – volume: 4 start-page: 1 year: 2019 ident: ref_49 article-title: Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles publication-title: Signal Transduct. Target. Ther. – ident: ref_61 doi: 10.1007/978-1-4614-0881-9 – volume: 10 start-page: 1650 year: 2020 ident: ref_138 article-title: Ultrasound-Responsive Materials for Drug/Gene Delivery publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.01650 – volume: 7 start-page: 489 year: 2020 ident: ref_70 article-title: Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases publication-title: Front. Bioeng. Biotechnol. doi: 10.3389/fbioe.2019.00489 – volume: 12 start-page: 5421 year: 2017 ident: ref_130 article-title: Quantum dots in imaging, drug delivery and sensor applications publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S138624 – volume: 44 start-page: 313 year: 2000 ident: ref_38 article-title: Present and future in vitro approaches for drug metabolism publication-title: J. Pharmacol. Toxicol. Methods doi: 10.1016/S1056-8719(00)00110-6 – ident: ref_41 doi: 10.5772/61160 – volume: 49 start-page: 109 year: 2002 ident: ref_27 article-title: Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7 years—A pilot study publication-title: Anesth. Prog. – ident: ref_65 doi: 10.5772/intechopen.93368 – volume: 11 start-page: 1 year: 2021 ident: ref_177 article-title: Application of Quantum Dots in Drug Delivery publication-title: Nanosci. Nanotechnol. Asia – volume: 16 start-page: 1681 year: 2021 ident: ref_103 article-title: Carbon Nanotubes: Smart Drug/Gene Delivery Carriers publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S299448 – volume: 49 start-page: 1993 year: 2008 ident: ref_110 article-title: Hydrogels in drug delivery: Progress and challenges publication-title: Polymer doi: 10.1016/j.polymer.2008.01.027 – volume: 20 start-page: 34 year: 2021 ident: ref_74 article-title: Nanotechnology: Its application in treating neurodegenerative diseases publication-title: CNS Neurol. Disord. Drug Targets doi: 10.2174/1871527319666200916121515 – ident: ref_83 doi: 10.3390/pharmaceutics11110591 – ident: ref_135 – ident: ref_172 – ident: ref_43 doi: 10.1016/B978-0-12-817909-3.00001-7 – volume: 51 start-page: 672 year: 2019 ident: ref_92 article-title: Electrospun nanofibers for customized drug-delivery systems publication-title: J. Drug Deliv. Sci. Technol. doi: 10.1016/j.jddst.2019.03.038 – volume: 4 start-page: 8790 year: 2020 ident: ref_93 article-title: Current Progress of Electrospun Nanocarriers for Drug Delivery Applications publication-title: Proceedings – volume: 618 start-page: 102 year: 1991 ident: ref_40 article-title: Concepts of circadian chronopharmacology publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1991.tb27239.x – volume: 2 start-page: 4055 year: 2014 ident: ref_81 article-title: Dendrimers for drug delivery publication-title: J. Mater. Chem. B doi: 10.1039/C4TB00171K – ident: ref_46 doi: 10.1016/B978-012369417-1/50058-4 – volume: 18 start-page: 1 year: 2021 ident: ref_123 article-title: Metallic nanoparticles as drug delivery system for the treatment of cancer publication-title: Expert Opin. Drug Deliv. – ident: ref_133 doi: 10.3390/nano11081968 – volume: 12 start-page: 252 year: 2018 ident: ref_127 article-title: Nanocapsules for drug delivery: An updated review of the last decade publication-title: Recent Pat. Drug Deliv. Formul. – volume: 7 start-page: 319 year: 2020 ident: ref_90 article-title: Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects publication-title: Front. Mol. Biosci. – volume: 6 start-page: 2963 year: 2011 ident: ref_104 article-title: A new era of cancer treatment: Carbon nanotubes as drug delivery tools publication-title: Int. J. Nanomed. – ident: ref_147 doi: 10.3390/md15040096 – volume: 1 start-page: 203 year: 2006 ident: ref_55 article-title: Osmotic controlled drug delivery systems publication-title: Des. Control. Release Drug Deliv. Syst. – ident: ref_59 – volume: 30 start-page: 1705328 year: 2018 ident: ref_48 article-title: Advances in biomaterials for drug delivery publication-title: Adv. Mater. doi: 10.1002/adma.201705328 – ident: ref_30 – volume: 6 start-page: 265 year: 2021 ident: ref_96 article-title: Bacterial Cellulose-Based Drug Delivery System for Dual Mode Drug Release publication-title: Trans. Indian Natl. Acad. Eng. doi: 10.1007/s41403-020-00192-w – volume: 15 start-page: 1903060 year: 2019 ident: ref_153 article-title: Remote Light-Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives publication-title: Small doi: 10.1002/smll.201903060 – volume: 69 start-page: 1090 year: 2020 ident: ref_126 article-title: Recent pros and cons of nanomaterials in drug delivery systems publication-title: Int. J. Polym. Mater. Polym. Biomater. doi: 10.1080/00914037.2019.1655753 – volume: 8 start-page: 3 year: 2018 ident: ref_120 article-title: Dendrimers: Nanosized multifunctional platform for drug delivery publication-title: Drug Deliv. Lett. – ident: ref_64 doi: 10.1002/9780470640487.ch15 – volume: 23 start-page: 328 year: 2016 ident: ref_143 article-title: Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon publication-title: Drug Deliv. doi: 10.3109/10717544.2014.913733 – volume: 190 start-page: 3 year: 2014 ident: ref_47 article-title: Controlled drug delivery systems: Past forward and future back publication-title: J. Control. Release doi: 10.1016/j.jconrel.2014.03.054 – ident: ref_11 – ident: ref_142 doi: 10.3390/molecules25235649 – volume: 13 start-page: e1678 year: 2021 ident: ref_148 article-title: Reduction-responsive polymers for drug delivery in cancer therapy—Is there anything new to discover? publication-title: Wiley Interdiscip. Rev. Nanomed. Nanobiotechnology doi: 10.1002/wnan.1678 – ident: ref_151 doi: 10.3390/pharmaceutics12090876 – volume: 524 start-page: 41 year: 2017 ident: ref_106 article-title: Functionalized single-walled carbon nanotubes: Cellular uptake, biodistribution and applications in drug delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2017.03.017 – volume: 87 start-page: 110 year: 2021 ident: ref_95 article-title: Drug release behaviour and mechanism from unmodified and in situ modified bacterial cellulose publication-title: Proc. Indian Natl. Sci. Acad. doi: 10.1007/s43538-021-00012-x – volume: 293 start-page: 183 year: 2005 ident: ref_32 article-title: Prediction of oral drug absorption in humans by theoretical passive absorption model publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.01.005 – volume: 25 start-page: 1513 year: 2020 ident: ref_124 article-title: Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2020.06.006 – ident: ref_39 doi: 10.1016/B978-0-12-369521-5.00009-9 – volume: 54 start-page: 1775 year: 2021 ident: ref_149 article-title: Degradable Redox-Responsive Polyolefins publication-title: Macromolecules doi: 10.1021/acs.macromol.1c00010 – volume: 245 start-page: 119987 year: 2020 ident: ref_169 article-title: Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis publication-title: Biomaterials doi: 10.1016/j.biomaterials.2020.119987 – volume: 161 start-page: 351 year: 2012 ident: ref_54 article-title: Modeling of diffusion controlled drug delivery publication-title: J. Control. Release doi: 10.1016/j.jconrel.2011.10.006 – ident: ref_73 – volume: 10 start-page: 39722 year: 2020 ident: ref_114 article-title: A sodium alginate-based sustained-release IPN hydrogel and its applications publication-title: RSC Adv. doi: 10.1039/D0RA04316H – ident: ref_156 doi: 10.3390/polym10101098 – volume: 2 start-page: 1006 year: 2011 ident: ref_6 article-title: New pharmaceutical excipients in solid dosage forms-A review publication-title: Int. J. Pharm. Life Sci. – volume: 5 start-page: 1 year: 2012 ident: ref_115 article-title: Nanotechnology and medicine-The upside and the downside publication-title: Int. J. Drug Dev. Res. – volume: 426 start-page: 755 year: 2017 ident: ref_94 article-title: Effect of micropatterning induced surface hydrophobicity on drug release from electrospun cellulose acetate nanofibers publication-title: Appl. Surf. Sci. doi: 10.1016/j.apsusc.2017.07.197 – ident: ref_132 doi: 10.1002/9781119711698.ch5 – ident: ref_164 doi: 10.3390/molecules26092797 – volume: 179 start-page: 43 year: 1971 ident: ref_37 article-title: Factors affecting drug metabolism publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1971.tb46890.x – volume: 36 start-page: 233 year: 1999 ident: ref_31 article-title: Drug, meal and formulation interactions influencing drug absorption after oral administration publication-title: Clin. Pharmacokinet. doi: 10.2165/00003088-199936030-00004 – ident: ref_154 doi: 10.3389/conf.FBIOE.2016.01.00807 – volume: 3 start-page: 12 year: 1998 ident: ref_100 article-title: Structural properties of self-assembled polymeric micelles publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/S1359-0294(98)80036-8 – volume: 41 start-page: 389 year: 2000 ident: ref_109 article-title: The study of gelation kinetics and chain-relaxation properties of glutaraldehyde-cross-linked chitosan gel and their effects on microspheres preparation and drug release publication-title: Carbohydr. Polym. doi: 10.1016/S0144-8617(99)00104-6 – ident: ref_118 doi: 10.1007/978-3-662-49320-5_25 – ident: ref_119 doi: 10.3390/molecules25173982 – volume: 8 start-page: 607 year: 2020 ident: ref_160 article-title: Thermoresponsive polymers and their biomedical application in tissue engineering–A review publication-title: J. Mater. Chem. B doi: 10.1039/C9TB02052G – ident: ref_170 doi: 10.3390/molecules23010047 – volume: 308 start-page: 172 year: 2019 ident: ref_150 article-title: Enzyme responsive drug delivery systems in cancer treatment publication-title: J. Control. Release doi: 10.1016/j.jconrel.2019.07.004 – volume: 10 start-page: 208 year: 2008 ident: ref_8 article-title: Use of the biopharmaceutical classification system in early drug development publication-title: AAPS J. doi: 10.1208/s12248-008-9020-0 – ident: ref_36 – volume: 13 start-page: 2507 year: 2018 ident: ref_107 article-title: Nanoemulsions in drug delivery: Formulation to medical application publication-title: Nanomedicine doi: 10.2217/nnm-2018-0088 – volume: 6 start-page: 6819 year: 2015 ident: ref_157 article-title: Tunable LCST behavior of poly(N-isopropylacrylamide/ionic liquid) copolymers publication-title: Polym. Chem. doi: 10.1039/C5PY00998G – volume: 1 start-page: 236 year: 2007 ident: ref_57 article-title: An overview of recent patents on oral osmotic drug delivery systems publication-title: Recent Pat. Drug Deliv. Formul. doi: 10.2174/187221107782331638 – volume: 392 start-page: 5 year: 1998 ident: ref_1 article-title: Drug delivery and targeting publication-title: Nature – volume: 13 start-page: 571 year: 2010 ident: ref_51 article-title: Osmotically controlled drug delivery system with associated drugs publication-title: J. Pharm. Pharm. Sci. doi: 10.18433/J38W25 – volume: 321 start-page: 324 year: 2020 ident: ref_98 article-title: Functionalized silk fibroin nanofibers as drug carriers: Advantages and challenges publication-title: J. Control. Release doi: 10.1016/j.jconrel.2020.02.022 – volume: 13 start-page: 102426 year: 2021 ident: ref_76 article-title: Nanocarriers for targeted drug delivery publication-title: J. Drug Deliv. Sci. Technol. doi: 10.1016/j.jddst.2021.102426 – ident: ref_113 doi: 10.3390/pharmaceutics13030357 – volume: 59 start-page: 237 year: 2011 ident: ref_131 article-title: Quantum dots in cell biology publication-title: J. Histochem. Cytochem. doi: 10.1369/0022155411398487 – volume: 26 start-page: 1261 year: 2008 ident: ref_17 article-title: Transdermal drug delivery publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1504 – ident: ref_53 doi: 10.1007/978-1-4614-0881-9 – volume: Volume 5 start-page: 267 year: 2008 ident: ref_22 article-title: Semisolid dosages: Ointments, creams and gels publication-title: Pharmaceutical Manufacturing Handbook: Production and Processes – volume: 16 start-page: 1081 year: 2019 ident: ref_179 article-title: Shaping the future: Recent advances of 3D printing in drug delivery and healthcare publication-title: Expert Opin. Drug Deliv. doi: 10.1080/17425247.2019.1660318 – ident: ref_171 – volume: 20 start-page: 3601 year: 2019 ident: ref_158 article-title: Reversible thermoresponsive peptide–PNIPAM hydrogels for controlled drug delivery publication-title: Biomacromolecules doi: 10.1021/acs.biomac.9b01009 – volume: 166 start-page: 91 year: 1951 ident: ref_26 article-title: Linctuses publication-title: Practitioner – ident: ref_128 doi: 10.1201/9781420008449 – volume: 5 start-page: 3596 year: 2014 ident: ref_13 article-title: Recent advances in semisolid dosage form publication-title: Int. J. Pharm. Sci. Res. – volume: 4 start-page: 3019 year: 2016 ident: ref_163 article-title: Nano-engineered electro-responsive drug delivery systems publication-title: J. Mater. Chem. B doi: 10.1039/C6TB00049E – ident: ref_35 – volume: 6 start-page: 227 year: 2012 ident: ref_161 article-title: Drug release from electric-field-responsive nanoparticles publication-title: ACS Nano doi: 10.1021/nn203430m – volume: 5 start-page: 1471 year: 2016 ident: ref_24 article-title: Pharmaceutical suspensions: Patient compliance oral dosage forms publication-title: World J. Pharm. Pharm. Sci. – ident: ref_58 – ident: ref_175 doi: 10.3390/s19061279 – ident: ref_2 doi: 10.1016/B978-0-12-816137-1.00078-7 – volume: 1 start-page: 21 year: 2012 ident: ref_4 article-title: Pharmaceutical excipients: A review publication-title: IJAPBC – volume: 111 start-page: 117 year: 2013 ident: ref_146 article-title: pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells publication-title: Colloids Surf. B Biointerfaces doi: 10.1016/j.colsurfb.2013.05.018 – ident: ref_121 doi: 10.20944/preprints201810.0507.v1 – volume: 8 start-page: 89 year: 2017 ident: ref_152 article-title: Recent advances in light-responsive on-demand drug-delivery systems publication-title: Ther. Deliv. doi: 10.4155/tde-2016-0060 – volume: 71 start-page: 1185 year: 2019 ident: ref_75 article-title: An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites publication-title: J. Pharm. Pharmacol. doi: 10.1111/jphp.13098 – volume: 15 start-page: 1360 year: 2018 ident: ref_99 article-title: A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Matrices publication-title: Curr. Drug Deliv. doi: 10.2174/1567201815666180723114326 – volume: 177 start-page: 275 year: 2017 ident: ref_111 article-title: Synthesis and characterization of a multi-sensitive polysaccharide hydrogel for drug delivery publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2017.08.133 – ident: ref_52 – volume: 9 start-page: 100585 year: 2020 ident: ref_89 article-title: Bacterial cellulose with microencapsulated antifungal essential oils: A novel double barrier release system publication-title: Materialia doi: 10.1016/j.mtla.2020.100585 – volume: 72 start-page: 5566 year: 2012 ident: ref_116 article-title: Overcoming limitations in nanoparticle drug delivery: Triggered, intravascular release to improve drug penetration into tumors publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-1683 – volume: 53 start-page: 1596 year: 2018 ident: ref_88 article-title: Broad-spectrum antimicrobial activity of bacterial cellulose silver nanocomposites with sustained release publication-title: Int. J. Mol. Sci. – volume: 3 start-page: 95 year: 2020 ident: ref_136 article-title: pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics publication-title: Commun. Biol. doi: 10.1038/s42003-020-0817-4 – volume: 10 start-page: 10 year: 2019 ident: ref_145 article-title: A Smart pH-Sensitive Delivery System for Enhanced Anticancer Efficacy via Paclitaxel Endosomal Escape publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.00010 – volume: 73 start-page: 1285 year: 2021 ident: ref_45 article-title: Narrow Therapeutic Index drugs: Clinical pharmacology perspective publication-title: J. Pharm. Pharmacol. doi: 10.1093/jpp/rgab102 – volume: 7 start-page: 12045 year: 2017 ident: ref_79 article-title: Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system publication-title: Sci. Rep. doi: 10.1038/s41598-017-11533-1 – volume: 20 start-page: 195 year: 2020 ident: ref_122 article-title: Exosomes: Structure, biogenesis, types and application in diagnosis and gene and Drug delivery publication-title: Curr. Gene Ther. doi: 10.2174/1566523220999200731011702 – volume: 13 start-page: 655 year: 2014 ident: ref_50 article-title: Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4363 – volume: 17 start-page: 849 year: 2019 ident: ref_72 article-title: Nanocarriers for drug delivery applications publication-title: Environ. Chem. Lett. doi: 10.1007/s10311-018-00841-1 – volume: 1 start-page: 54 year: 2010 ident: ref_9 article-title: Research. Routes of drug administration publication-title: Int. J. Pharm. Stud. Res. – volume: 11 start-page: 3183 year: 2021 ident: ref_84 article-title: Engineering exosomes for targeted drug delivery publication-title: Theranostics doi: 10.7150/thno.52570 – volume: 90 start-page: 1 year: 2019 ident: ref_159 article-title: Advances in injectable self-healing biomedical hydrogels publication-title: Acta Biomater. doi: 10.1016/j.actbio.2019.03.057 – ident: ref_167 doi: 10.3390/fluids3040074 – volume: 19 start-page: 100311 year: 2021 ident: ref_141 article-title: Smart biomaterials-A proposed definition and overview of the field publication-title: Curr. Opin. Biomed. Eng. doi: 10.1016/j.cobme.2021.100311 – volume: 18 start-page: 228 year: 2014 ident: ref_16 article-title: Basics of compounding: Tips and hints, Part 3: Compounding with ointments, creams, pastes, gels, and gel-creams publication-title: Int. J. Pharm. Compd. – volume: 8 start-page: 12 year: 2018 ident: ref_44 article-title: Release kinetics–concepts and applications publication-title: Int. J. Pharm. Res. Technol. – ident: ref_34 – volume: 19 start-page: 2459 year: 2018 ident: ref_137 article-title: Unravelling the Excellent Chemical Stability and Bioavailability of Solvent Responsive Curcumin-Loaded 2-Ethyl-2-oxazoline-grad-2-(4-dodecyloxyphenyl)-2-oxazoline Copolymer Nanoparticles for Drug Delivery publication-title: Biomacromolecules doi: 10.1021/acs.biomac.8b00057 – ident: ref_173 – volume: 249 start-page: 116816 year: 2020 ident: ref_97 article-title: Ex-situ modification of bacterial cellulose for immediate and sustained drug release with insights into release mechanism publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2020.116816 – volume: 210 start-page: 122993 year: 2020 ident: ref_112 article-title: Supramolecular hydrogels: Mechanical strengthening with dynamics publication-title: Polymer doi: 10.1016/j.polymer.2020.122993 – volume: 110 start-page: 375 year: 2018 ident: ref_155 article-title: NIR triggered liposome gold nanoparticles entrapping curcumin as in situ adjuvant for photothermal treatment of skin cancer publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2017.11.163 – volume: 1 start-page: 267 year: 2008 ident: ref_15 article-title: Semisolid dosages: Ointments, creams, and gels publication-title: Pharm. Manuf. Handb. doi: 10.1002/9780470259818.ch9 – volume: 6 start-page: 286 year: 2015 ident: ref_77 article-title: Advances and Challenges of Liposome Assisted Drug Delivery publication-title: Front. Pharmacol. doi: 10.3389/fphar.2015.00286 – volume: 3 start-page: 26 year: 2011 ident: ref_20 article-title: Transdermal patches: A recent approach to new drug delivery system publication-title: Int. J. Pharm. Pharm. Sci. – volume: 19 start-page: 475 year: 2011 ident: ref_129 article-title: Fluorescence nanoparticles “quantum dots” as drug delivery system and their toxicity: A review publication-title: J. Drug Target. doi: 10.3109/1061186X.2010.526227 – volume: 16 start-page: 71 year: 2018 ident: ref_86 article-title: Nano based drug delivery systems: Recent developments and future prospects publication-title: J. Nanobiotechnology doi: 10.1186/s12951-018-0392-8 – volume: 8 start-page: 1621 year: 2013 ident: ref_166 article-title: Potential and problems in ultrasound-responsive drug delivery systems publication-title: Int. J. Nanomed. – ident: ref_21 – ident: ref_105 doi: 10.1016/B978-0-12-814031-4.00005-2 – ident: ref_14 doi: 10.1201/9781315102856 – volume: 4 start-page: 69 year: 2015 ident: ref_67 article-title: Polymers in drug delivery publication-title: J. Biosci. Med. – ident: ref_10 doi: 10.1201/b15115 – volume: 65 start-page: 49 year: 2013 ident: ref_62 article-title: Polymer–drug conjugates: Origins, progress to date and future directions publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2012.10.014 – volume: 3 start-page: 72 year: 2020 ident: ref_174 article-title: Molecular imprinting: A useful approach for drug delivery publication-title: Mater. Sci. Energy Technol. – volume: 133 start-page: 94 year: 2017 ident: ref_101 article-title: Self assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2017.04.022 – ident: ref_134 doi: 10.1039/9781788013536-00001 – volume: 7 start-page: 15 year: 2017 ident: ref_80 article-title: Liposomes for drug delivery publication-title: Drugs – volume: 65 start-page: 36 year: 2013 ident: ref_78 article-title: Liposomal drug delivery systems: From concept to clinical applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2012.09.037 – volume: 72 start-page: 55 year: 2018 ident: ref_162 article-title: Injectable antibacterial conductive hydrogels with dual response to an electric field and pH for localized “smart” drug release publication-title: Acta Biomater. doi: 10.1016/j.actbio.2018.03.018 – volume: 11 start-page: 3232 year: 2020 ident: ref_176 article-title: Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing publication-title: Nat. Commun. doi: 10.1038/s41467-020-17029-3 – volume: 25 start-page: 1668 year: 2020 ident: ref_178 article-title: 3D printing for drug delivery and biomedical applications publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2020.07.007 – ident: ref_29 – volume: 69 start-page: 197 year: 2019 ident: ref_19 article-title: Transdermal patches: Design and current approaches to painless drug delivery publication-title: Acta Pharm. doi: 10.2478/acph-2019-0016 – ident: ref_12 – volume: 3 start-page: 115 year: 2004 ident: ref_18 article-title: Current status and future potential of transdermal drug delivery publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1304 – volume: 95 start-page: 4 year: 2006 ident: ref_25 article-title: Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol) publication-title: J. Pharm. Sci. doi: 10.1002/jps.20477 – volume: 14 start-page: 847 year: 2020 ident: ref_168 article-title: Comparative study of nanoparticle uptake and impact in murine lung, liver and kidney tissue slices publication-title: Nanotoxicology doi: 10.1080/17435390.2020.1771785 – volume: 4 start-page: 022001 year: 2009 ident: ref_69 article-title: Stimuli-responsive polymers and their applications in drug delivery publication-title: Biomed. Mater. doi: 10.1088/1748-6041/4/2/022001 – ident: ref_60 – ident: ref_82 doi: 10.3390/molecules23040938 – volume: 2008 start-page: 469531 year: 2008 ident: ref_66 article-title: Synthetic polymers as drug-delivery vehicles in medicine publication-title: Met. Based Drugs doi: 10.1155/2008/469531 – volume: 6 start-page: 609 year: 2018 ident: ref_140 article-title: Magnetic Drug Delivery: Where the Field Is Going publication-title: Front. Chem. doi: 10.3389/fchem.2018.00619 – volume: 193 start-page: 122 year: 2014 ident: ref_71 article-title: Sustained-release from nanocarriers: A review publication-title: J. Control. Release doi: 10.1016/j.jconrel.2014.05.029 – volume: 5 start-page: 124 year: 2015 ident: ref_125 article-title: Mesoporous silica nanoparticles in target drug delivery system: A review publication-title: Int. J. Pharm. Investig. doi: 10.4103/2230-973X.160844 – volume: 13 start-page: 2535 year: 2006 ident: ref_7 article-title: Drug excipients publication-title: Curr. Med. Chem. doi: 10.2174/092986706778201648 – volume: 9 start-page: 2 year: 2018 ident: ref_56 article-title: A review: Osmotic drug delivery system publication-title: Pharma Sci. Monit. – volume: Volume 5 start-page: 313 year: 2008 ident: ref_23 article-title: Liquid dosage forms publication-title: Pharmaceutical Manufacturing Handbook: Production and Processes – volume: 16 start-page: 1 year: 2018 ident: ref_85 article-title: Recent advancements in the use of exosomes as drug delivery systems publication-title: J. Nanobiotechnology doi: 10.1186/s12951-018-0403-9 – volume: 138 start-page: 56 year: 2019 ident: ref_139 article-title: Electric field-responsive nanoparticles and electric fields: Physical, chemical, biological mechanisms and therapeutic prospects publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2018.10.017
SSID	ssj0021415
Score	2.7249901
SecondaryResourceType	review_article
Snippet	The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery...
SourceID	doaj pubmedcentral proquest crossref
SourceType	Open Website Open Access Repository Aggregation Database Enrichment Source Index Database
StartPage	5905
SubjectTerms	Bioavailability Carbon dioxide Classification controlled release dosage forms Drug delivery systems Drug dosages Ingredients intelligent biomaterials nano-drug delivery Oral administration Permeability pharmacokinetics Review smart and stimuli-responsive delivery Taste
SummonAdditionalLinks	– databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSsNAFB2kG92IT6xWGcGVEJp5tJm402oogq4sdBcyLxVqKm2z8O-9M5mUBkE3bpPJ68xN7jnMzbkIXaWFlcAcZKSoYRE3XEfSmiQquBHaykIbXzz-9DwcT_jjdDDdaPXlasJqe-AauL6STKWK6EQL0CKSFoY6x3GeUKatSP1vvpDzGjEVpBaBvFSvYTIQ9f2PutWsWTq9MEhdr7qNLOTN-lsMs10fuZFwsj20G5givq3vcB9tmfIAbY-aBm2HKBvVZeYzo_H9onrF92bmqiy-cLAhv8HBfQk7SlktcVFqnHkTERw-dRBzR2iSPbyMxlFoixApnsSriBCtLeQUCjimMdXwDmqlKQAlh8IyS4UaSKWoTLj2Co5KZklCCCuE4USxY9Qp56U5QViJVFoJZ1XOJcaCsE4hYbNEWECbaN5FcQNTroJnuGtdMctBOzhk8x_IdtH1-pDP2jDjt8F3Dvv1QOd17TdABOQhAvK_IqCLes3M5eEFXOZ0IGJHvRhc43K9GybIrYcUpZlXfgyoKw4UqIuS1oy3bqi9p3x_8ybcwFRBvdHT_3iCM7RDXamMW-xKe6izWlTmHLjOSl74sP4GjuABSA priority: 102 providerName: Directory of Open Access Journals
Title	Controlled Drug Delivery Systems: Current Status and Future Directions
URI	https://www.proquest.com/docview/2580993735 https://www.proquest.com/docview/2581824201 https://pubmed.ncbi.nlm.nih.gov/PMC8512302 https://doaj.org/article/cb3c9c1d7d8840b2ae220674723df898
Volume	26
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5Be4AL4ilCy8pInJCiJrZTO1wQ3TZUSFQIUWlvUfwqSEu27OPQf8-M4902Quolh9hJnBnb841n9A3A-7oLBpGDyS33IpdeutwEr_JOeu2C6ZyPyePfLo7PL-XXWTVLB26rlFa53RPjRu0Wls7Ij3ilC7Klovp0_TenqlEUXU0lNB7CPlGXUUqXmt06XCVapyGSKdC1P_ozFJz1K_Iaqpoq1t2xRZGyf4Qzx1mSd8xO8xSeJLzIPg8KfgYPfP8cHk23ZdpeQDMdks3n3rHT5eaKnfo55VrcsERG_pElDiZGwHKzYl3vWBOpRFja8HDmvYTL5uzn9DxPxRFyK1WxzsvSuYCWhaM064I7XInOOm6NMMc6iMC1rYy13Cjpoh_HjQilKkvRaS9LK17BXr_o_WtgVtcmGHyrJa6YgO51jWZbKB2cRjgrMyi2YmptYg6nAhbzFj0Ikmz7n2Qz-LB75Hqgzbiv8wnJfteRGK_jjcXyqk0LqMUfs7UtncIxycLwznNinpeKCxd0rTM43GquTctw1d5Omgze7ZpRQRQV6Xq_2MQ-6GNJBEIZqJHGRwMat_S_f0UqbsSr6MPxN_d__AAec0qFoWBWfQh76-XGv0UsszaTOGHxqpsvE9g_Obv4_mMSzwX-Aef2_H0
linkProvider	ProQuest
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VcigXxFOEFjASXJCiJrbTOEgIwS5hSx-nVuotxK-CtM2WfQj1T_EbmXGSpRFSb73GjuOMZ8bfxJNvAN4UtdeIHHRsuBOxdNLG2rs8rqVT1uvaupA8fnS8NzmV386ysw340_8LQ2mVvU8MjtrODH0j3-WZSmgvFdnHy18xVY2i09W-hEarFgfu6jeGbIsP-2Nc37ecl19ORpO4qyoQG5knyzhNrfXokjlOo0i4RRW2xnKjhd5TXniuTKaN4TqXNgRAXAuf5mkqauVkagSOewfuSiEKsihVfl0HeCnuhu3JKTYmuxdtgVu3oCglK6hC3rW9L5QIGODaYVbmtW2ufAD3O3zKPrUK9RA2XPMItkZ9WbjHUI7a5Paps2w8X52zsZtSbscV68jP37OO84kRkF0tWN1YVgbqEtY5WNT0J3B6K2J7CpvNrHHPgBlVaK9xVEPcNB7D-QJhgsiVtwrhs4wg6cVUmY6pnApmTCuMWEiy1X-SjeDd-pbLlqbjps6fSfbrjsSwHS7M5udVZ7AVvpgpTGpznJNMNK8dJ6Z7mXNhvSpUBDv9ylWd2S-qf0oawet1My4QncLUjZutQh-M6SQCrwjywYoPJjRsaX7-CNTfiI8xZuTPb374K9ianBwdVof7xwfbcI9TGg4dpBU7sLmcr9wLxFFL_TIoL4Pvt20tfwHM0TXZ
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxFOkFDASXJCijR9pHCSEYJeopVBxoNLeQvwqSNts2YdQ_xq_jpk8to2Qeus1dhxnPB5_k5l8A_Aqr4JB5GBiK7yMlVcuNsFncaW8dsFUzjfJ41-P9vaP1edpOt2Cv_2_MJRW2dvExlC7uaVv5COR6oTOUpmOQpcW8W1SvD_7HVMFKYq09uU0WhU59Od_0H1bvjuY4Fq_FqL49H28H3cVBmKrsmQVc-5cQPMscEp5Ihyqs7NOWCPNng4yCG1TY60wmXKNMySMDDzjXFbaK24ljnsDbuKkOO2xbHrh7HE8GdsoqpR5Mjpti936JXksaU7V8i6dg025gAHGHWZoXjryintwt8Oq7EOrXPdhy9cP4Pa4LxH3EIpxm-g-845NFusTNvEzyvM4Zx0R-lvW8T8xArXrJatqx4qGxoR1xha1_hEcX4vYHsN2Pa_9E2BW5yYYHNUST01A1z5HyCAzHZxGKK0iSHoxlbZjLafiGbMSvReSbPmfZCN4s7nlrKXsuKrzR5L9piOxbTcX5ouTstu8Jb6YzS13Gc5JJUZUXhDrvcqEdEHnOoLdfuXKzgQsywuFjeDlphkXiCIyVe3n66YP-ncKQVgE2WDFBxMattS_fjY04IiV0X8UO1c__AXcwn1Sfjk4OnwKdwRl5FBMLd-F7dVi7Z8hpFqZ543uMvhx3ZvlH795OgY
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Controlled+Drug+Delivery+Systems%3A+Current+Status+and+Future+Directions&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Adepu%2C+Shivakalyani&rft.au=Ramakrishna%2C+Seeram&rft.date=2021-09-29&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=26&rft.issue=19&rft.spage=5905&rft_id=info:doi/10.3390%2Fmolecules26195905&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon